COVID-19 Vaccination: Information for Health Care Providers

Key points

Two types of COVID-19 vaccines are recommended for use in the United States: mRNA vaccines (Moderna and Pfizer-BioNTech) and a protein subunit vaccine (Novavax).

Recommendations

Vaccination is based on individual-based decision-making (also known as shared clinical decision-making). Schedules and dosing for the 2025–2026 COVID-19 vaccines are based on age and immune status.

Keep Reading Overview of COVID-19 Vaccines and Vaccination

Clinical tools

Immunization schedules

Prevaccination screening checklist

Education for patients and parents

Immunization providers should provide a Vaccine Information Statement (VIS) to a patient, parent, or legal representative before each dose of COVID-19 vaccine.

Keep Reading COVID-19 Vaccine VIS

Storage labels

Includes labels and beyond-use date guidance for flu, COVID-19, and RSV immunization products

2025-2026 product information

Pfizer-BioNTech

Package Insert – COMIRNATY

Moderna

Package Insert – SPIKEVAX

Package Insert – MNEXSPIKE

Novavax

Package Insert and Patient Package Insert – Nuvaxovid

Resources

Print
Content Source:
National Center for Immunization and Respiratory Diseases; Immunization Services Division